Pacritinib dosing, indications, interactions, adverse effects, and more

Sections

Sections pacritinib
Dosing & Uses
Pharmacology
Images
Patient Handout
Formulary

Dosing & Uses

Myelofibrosis

Pending FDA approval for intermediate and high-risk myelofibrosis

Mechanism of Action

Tyrosine kinase inhibitor (TKI); inhibits 4 mutations of the JAK signal transduction pathways (ie, JAK2, FLT3, IRAK1 and CSF1R); mutations in these kinases have been shown to be related to a the development of a variety of blood-related cancers, including myelofibrosis

The JAK family of enzymes is critical for normal blood cell growth and development, as well as inflammatory cytokine expression and immune responses

Images

Patient Handout

Formulary

FormularyPatient Discounts

Adding plans allows you to compare formulary status to other drugs in the same class.

To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.

Create Your List of Plans

Adding plans allows you to:

View the formulary and any restrictions for each plan.
Manage and view all your plans together – even plans in different states.
Compare formulary status to other drugs in the same class.
Access your plan list on any device – mobile or desktop.

The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.

View explanations for tiers and restrictions

Tier	Description
1	This drug is available at the lowest co-pay. Most commonly, these are generic drugs.
2	This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.
3	This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.
4	This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
5	This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
6	This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
NC	NOT COVERED – Drugs that are not covered by the plan.

Code	Definition
PA	Prior Authorization Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
QL	Quantity Limits Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
ST	Step Therapy Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
OR	Other Restrictions Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.

Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.

[CLOSE WINDOW]

Sections pacritinib
Dosing & Uses
Pharmacology
Images
Patient Handout
Formulary

pacritinib (Rx)

Dosing & Uses

Myelofibrosis

Pharmacology

Mechanism of Action

Images

Patient Handout

Formulary

About

Membership

Apps

WebMD Network

Editions

What to Read Next on Medscape

pacritinib (Rx)

Dosing & Uses

Myelofibrosis

Pharmacology

Mechanism of Action

Images

Patient Handout

Formulary

Plans

What would you like to print?

Dosing Calculator

Find Us On

About

Membership

Apps

WebMD Network

Editions

What to Read Next on Medscape

Medscape Consult

News & Perspective

Tools

Drug Class

Slideshow

Most Popular Articles

Recommended